Arrowstreet Capital, Limited Partnership Myriad Genetics Inc Transaction History

Arrowstreet Capital, Limited Partnership

$121 Billion
Q3 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Myriad Genetics Inc stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 177,581 shares of MYGN stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

177,581

Holding current value

$2.22 Million

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.97 - $28.6 $4.26 Million - $5.08 Million	177,581 New	177,581 $4.86 Million
Q1 2021 May 14, 2021	SELL	$19.92 - $31.6 $363,818 - $577,142	-18,264 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$12.16 - $19.77 $6.27 Million - $10.2 Million	-515,954 Reduced 96.58%	18,264 $361,000
Q3 2020 Nov 12, 2020	SELL	$11.25 - $14.75 $3.47 Million - $4.55 Million	-308,782 Reduced 36.63%	534,218 $6.97 Million
Q2 2020 Aug 12, 2020	BUY	$10.69 - $16.49 $9.01 Million - $13.9 Million	843,000 New	843,000 $9.56 Million
Q1 2020 May 15, 2020	SELL	$9.78 - $29.53 $223,961 - $676,237	-22,900 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$20.93 - $35.1 $479,297 - $803,790	22,900 New	22,900 $624,000
Q4 2018 Feb 14, 2019	SELL	$27.23 - $45.56 $3.12 Million - $5.21 Million	-114,429 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $3.7 Million - $4.95 Million	98,429 Added 615.18%	114,429 $5.26 Million
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $339,882 - $492,002	-12,248 Reduced 43.36%	16,000 $598,000
Q1 2018 May 14, 2018	SELL	$28.83 - $41.01 $843,335 - $1.2 Million	-29,252 Reduced 50.87%	28,248 $835,000
Q4 2017 Feb 09, 2018	BUY	$28.45 - $37.14 $1.64 Million - $2.14 Million	57,500	57,500 $1.98 Million

Others Institutions Holding MYGN

# of Institutions

250

Shares Held

90.6M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.01B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Myriad Genetics Inc Transaction History